Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
CAS Number : 5267-64-1
End Use API : Amino Acids Mixture
About The Company : PMC Isochem is a CDMO company acquired by PMC International in 2017. It manufactures cGMP intermediates, active pharmaceutical ingredients and functional excipi...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Minamino
Dosage Form : SYR
Dosage Strength : 100mg/5ml
Packaging : 200X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Minamino
Dosage Form : SYR
Dosage Strength : 100mg/5ml
Packaging : 500X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 10% (10GM/100...DOSAGE - INJECTABLE;INJECTION - 10% (10GM/100ML)
USFDA APPLICATION NUMBER - 19018
DOSAGE - INJECTABLE;INJECTION - 6% (6GM/100ML...DOSAGE - INJECTABLE;INJECTION - 6% (6GM/100ML)
USFDA APPLICATION NUMBER - 19018
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML)
USFDA APPLICATION NUMBER - 200656
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory FDF Prices
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
16
PharmaCompass offers a list of Amino Acids Mixture API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amino Acids Mixture manufacturer or Amino Acids Mixture supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amino Acids Mixture manufacturer or Amino Acids Mixture supplier.
PharmaCompass also assists you with knowing the Amino Acids Mixture API Price utilized in the formulation of products. Amino Acids Mixture API Price is not always fixed or binding as the Amino Acids Mixture Price is obtained through a variety of data sources. The Amino Acids Mixture Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PERIKABIVEN IN PLASTIC CONTAINER manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PERIKABIVEN IN PLASTIC CONTAINER, including repackagers and relabelers. The FDA regulates PERIKABIVEN IN PLASTIC CONTAINER manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PERIKABIVEN IN PLASTIC CONTAINER API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A PERIKABIVEN IN PLASTIC CONTAINER supplier is an individual or a company that provides PERIKABIVEN IN PLASTIC CONTAINER active pharmaceutical ingredient (API) or PERIKABIVEN IN PLASTIC CONTAINER finished formulations upon request. The PERIKABIVEN IN PLASTIC CONTAINER suppliers may include PERIKABIVEN IN PLASTIC CONTAINER API manufacturers, exporters, distributors and traders.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A PERIKABIVEN IN PLASTIC CONTAINER DMF (Drug Master File) is a document detailing the whole manufacturing process of PERIKABIVEN IN PLASTIC CONTAINER active pharmaceutical ingredient (API) in detail. Different forms of PERIKABIVEN IN PLASTIC CONTAINER DMFs exist exist since differing nations have different regulations, such as PERIKABIVEN IN PLASTIC CONTAINER USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A PERIKABIVEN IN PLASTIC CONTAINER DMF submitted to regulatory agencies in the US is known as a USDMF. PERIKABIVEN IN PLASTIC CONTAINER USDMF includes data on PERIKABIVEN IN PLASTIC CONTAINER's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The PERIKABIVEN IN PLASTIC CONTAINER USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER suppliers with USDMF on PharmaCompass.
A PERIKABIVEN IN PLASTIC CONTAINER CEP of the European Pharmacopoeia monograph is often referred to as a PERIKABIVEN IN PLASTIC CONTAINER Certificate of Suitability (COS). The purpose of a PERIKABIVEN IN PLASTIC CONTAINER CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of PERIKABIVEN IN PLASTIC CONTAINER EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of PERIKABIVEN IN PLASTIC CONTAINER to their clients by showing that a PERIKABIVEN IN PLASTIC CONTAINER CEP has been issued for it. The manufacturer submits a PERIKABIVEN IN PLASTIC CONTAINER CEP (COS) as part of the market authorization procedure, and it takes on the role of a PERIKABIVEN IN PLASTIC CONTAINER CEP holder for the record. Additionally, the data presented in the PERIKABIVEN IN PLASTIC CONTAINER CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the PERIKABIVEN IN PLASTIC CONTAINER DMF.
A PERIKABIVEN IN PLASTIC CONTAINER CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. PERIKABIVEN IN PLASTIC CONTAINER CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing PERIKABIVEN IN PLASTIC CONTAINER as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for PERIKABIVEN IN PLASTIC CONTAINER API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture PERIKABIVEN IN PLASTIC CONTAINER as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain PERIKABIVEN IN PLASTIC CONTAINER and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a PERIKABIVEN IN PLASTIC CONTAINER NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of PERIKABIVEN IN PLASTIC CONTAINER suppliers with NDC on PharmaCompass.
PERIKABIVEN IN PLASTIC CONTAINER Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PERIKABIVEN IN PLASTIC CONTAINER GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PERIKABIVEN IN PLASTIC CONTAINER GMP manufacturer or PERIKABIVEN IN PLASTIC CONTAINER GMP API supplier for your needs.
A PERIKABIVEN IN PLASTIC CONTAINER CoA (Certificate of Analysis) is a formal document that attests to PERIKABIVEN IN PLASTIC CONTAINER's compliance with PERIKABIVEN IN PLASTIC CONTAINER specifications and serves as a tool for batch-level quality control.
PERIKABIVEN IN PLASTIC CONTAINER CoA mostly includes findings from lab analyses of a specific batch. For each PERIKABIVEN IN PLASTIC CONTAINER CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PERIKABIVEN IN PLASTIC CONTAINER may be tested according to a variety of international standards, such as European Pharmacopoeia (PERIKABIVEN IN PLASTIC CONTAINER EP), PERIKABIVEN IN PLASTIC CONTAINER JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PERIKABIVEN IN PLASTIC CONTAINER USP).
